Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMarstons Regulatory News (MARS)

Share Price Information for Marstons (MARS)

Share Price is delayed by 15 minutes
Get Live Data
50.20    0.10 (0.20%)
Bid:
50.00
Ask:
50.30
Spread: 0.30 (0.60%)
Market Cap: £317.70m
MARS Live PriceLast checked at - London Stock Exchange

Intraday Marstons Share Chart

Director/PDMR Shareholding

28 Nov 2025 12:30

RNS Number : 4869J
Marston's PLC
28 November 2025
 

28 November 2025

 

Notification of interests of directors and persons discharging managerial responsibilities

Marston's PLC (the "Company") announces that on 27 November 2025 the Directors listed below were granted awards over ordinary shares in the Company under the Company's Long Term Incentive Plan (the "Plan").

 

The number of shares over which awards were granted was calculated using the market price at the close of trading on the London Stock Exchange on 27 November 2025, being £0.597 per ordinary share.

 

Awards under the Plan may comprise two elements:

 

(i) a nil-cost option (a "Nil-Cost Option"), and

 

(ii) a CSOP Option over shares with a total value at the date of grant of £60,000 (the statutory limit) with an exercise price of £0.597 per share (a "CSOP Option").

 

The awards will ordinarily vest on the third anniversary of the date of grant to the extent the performance metrics are satisfied. The performance metrics are based on Underlying Profit Before Tax (as regards 40% of the award), Operating Margin (as regards 30% of the award) and Relative Total Shareholder Return (as regards 30% of the award) assessed over the Company's 2026, 2027 and 2028 financial periods, details of which will be set out in the Company's Annual Report and Accounts for the period ended 27 September 2025.

 

To the extent the performance metrics are met, a Nil-Cost Option will be released following a two-year holding period.

 

Linking Arrangement between Nil-Cost Option and CSOP Option

The options granted to Stephen Hopson have been granted such that the maximum pre-tax value delivered to him will not exceed the value of the shares over which the Nil-Cost Option would have vested if it was a standalone option.

 

The CSOP option will be released only to the extent that the aggregate CSOP gain is less than or equal to the value of the shares over which the Nil-Cost Option would be released on the normal released date.

 

Name of individual

Designation

Number of shares subject to CSOP Option

Number of shares subject to Nil-Cost Option

Justin Platt

Director

N/A

1,590,452

Stephen Hopson

Director

100,502

785,175

 

The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

 

 

Enquiries:

Bethan Raybould, General Counsel & Company Secretary, Marston's PLC, +44 (0) 1902 907250

 

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Stephen Hopson

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Financial Officer)

 

b)

Initial notification/

amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a CSOP option with an exercise price of £0.597 per share and a nil-cost option.

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

785,175

CSOP option: £0.597

100,502

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

1.

Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA")

a)

Name

Justin Platt

 

2.

Reason for the notification

a)

Position/status

Director and PDMR (Chief Executive Officer)

 

b)

Initial notification/ amendment

Initial Notification

3.

Details of the Issuer

a)

Name

Marston's PLC

b)

LEI code

213800Q6RP3ZJ2CZR962

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification code

Ordinary Shares of 7.375 pence each

 

 

ISIN: GB00B1JQDM80

b)

Nature of the transaction

Grant of award under the Marston's PLC Long Term Incentive Plan in the form of a nil-cost option.

 

c)

Price(s) and volumes(s)

 

Price

Volume

Nil-cost option: N/A

1,590,452

d)

Aggregated information

- Aggregate volume

 

- Price

 

 

N/A

 

e)

Date of the transaction

2025-11-27

f)

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAAFPAAPSFFA
Date   Source Headline
10th Oct 20177:00 amRNSYear-End Trading Update
2nd Oct 20172:48 pmRNSTotal Voting Rights
29th Sep 201710:27 amRNSDirector/PDMR Shareholding
8th Sep 20172:20 pmRNSDirector/PDMR Shareholding
5th Sep 201711:55 amRNSDirectorate Change
1st Sep 20171:47 pmRNSTotal Voting Rights
26th Jul 20177:00 amRNSTrading Update
11th Jul 20178:41 amRNSBlock listing Interim Review
5th Jul 20174:18 pmRNSDirector/PDMR Shareholding
4th Jul 20179:04 amRNSDirector/PDMR Shareholding
28th Jun 20174:03 pmRNSDirector/PDMR Shareholding
22nd Jun 20173:06 pmRNSDirector/PDMR Shareholding
20th Jun 20172:13 pmRNSDirector/PDMR Shareholding
20th Jun 20177:01 amRNSDirector Declaration
2nd Jun 20174:45 pmRNSCompletion of Acquisition of Charles Wells
25th May 20173:12 pmRNSHolding(s) in Company
22nd May 20173:19 pmRNSTotal Voting Rights
18th May 20172:42 pmRNSDirector/PDMR Shareholding
18th May 201712:00 pmRNSResults of Placing
18th May 20177:00 amRNSProposed Placing
18th May 20177:00 amRNSAcquisition
18th May 20177:00 amRNSInterim Results
18th Apr 20172:31 pmRNSNotice of Revised Interim Results Reporting Date
3rd Apr 20171:40 pmRNSTotal Voting Rights
20th Mar 20177:00 amRNSNew Bank Facility
1st Mar 201711:56 amRNSTotal Voting Rights
22nd Feb 20172:30 pmRNSHolding(s) in Company
1st Feb 201711:41 amRNSTotal Voting Rights
25th Jan 201711:49 amRNSResult of AGM
24th Jan 20177:00 amRNSAGM Trading Update
19th Jan 201712:02 pmRNSHolding(s) in Company
10th Jan 20172:26 pmRNSBlock listing Interim Review
3rd Jan 20172:21 pmRNSTotal Voting Rights
19th Dec 20164:39 pmRNSDirector/PDMR Shareholding
16th Dec 20165:00 pmRNSAnnual Financial Report
13th Dec 20167:00 amRNSBoard Appointment
1st Dec 201612:11 pmRNSTotal Voting Rights
28th Nov 20163:04 pmRNSDirector/PDMR Shareholding
28th Nov 20163:02 pmRNSDirector/PDMR Shareholding
24th Nov 20167:00 amRNSPreliminary Results
1st Nov 20162:46 pmRNSTotal Voting Rights
12th Oct 20167:00 amRNSYear-End Trading Update
3rd Oct 20162:54 pmRNSTotal Voting Rights
21st Sep 20162:04 pmRNSDirector/PDMR Shareholding
21st Sep 20162:02 pmRNSDirector Declaration
21st Sep 20167:00 amRNSDirectorate Change
5th Sep 20163:23 pmRNSDirector/PDMR Shareholding
1st Sep 20163:18 pmRNSDirector/PDMR Shareholding
1st Sep 20163:08 pmRNSTotal Voting Rights
27th Jul 20167:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.